These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33361305)

  • 1. Interplay among Different Fosfomycin Resistance Mechanisms in Klebsiella pneumoniae.
    Ortiz-Padilla M; Portillo-Calderón I; de Gregorio-Iaria B; Blázquez J; Rodríguez-Baño J; Pascual A; Rodríguez-Martínez JM; Docobo-Pérez F
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.
    Ito R; Tomich AD; McElheny CL; Mettus RT; Sluis-Cremer N; Doi Y
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of
    Elliott ZS; Barry KE; Cox HL; Stoesser N; Carroll J; Vegesana K; Kotay S; Sheppard AE; Wailan A; Crook DW; Parikh H; Mathers AJ
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31340992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli.
    Guo Q; Tomich AD; McElheny CL; Cooper VS; Stoesser N; Wang M; Sluis-Cremer N; Doi Y
    J Antimicrob Chemother; 2016 Sep; 71(9):2460-5. PubMed ID: 27261267
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Lim TP; Teo JQ; Goh AW; Tan SX; Koh TH; Lee WH; Cai Y; Tan TT; Kwa AL
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. fosA3 overexpression with transporter mutations mediates high-level of fosfomycin resistance and silence of fosA3 in fosfomycin-susceptible Klebsiella pneumoniae producing carbapenemase clinical isolates.
    Singkham-In U; Muhummudaree N; Chatsuwan T
    PLoS One; 2020; 15(8):e0237474. PubMed ID: 32857767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Epidemiology of Plasmid-Mediated Fosfomycin Resistance Gene Determinants in Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae Isolates in China.
    Chen J; Wang D; Ding Y; Zhang L; Li X
    Microb Drug Resist; 2019 Mar; 25(2):251-257. PubMed ID: 30113251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and mechanisms of fosfomycin resistance among KPC-producing Klebsiella pneumoniae clinical isolates in China.
    Huang L; Cao M; Hu Y; Zhang R; Xiao Y; Chen G
    Int J Antimicrob Agents; 2021 Jan; 57(1):106226. PubMed ID: 33212165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China.
    Jiang Y; Shen P; Wei Z; Liu L; He F; Shi K; Wang Y; Wang H; Yu Y
    Int J Antimicrob Agents; 2015 Jan; 45(1):66-70. PubMed ID: 25450805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae.
    Albiero J; Sy SK; Mazucheli J; Caparroz-Assef SM; Costa BB; Alves JL; Gales AC; Tognim MC
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4128-39. PubMed ID: 27139468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing
    Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E
    Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of fosfomycin resistance mechanisms and molecular epidemiology in extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates.
    Lu PL; Hsieh YJ; Lin JE; Huang JW; Yang TY; Lin L; Tseng SP
    Int J Antimicrob Agents; 2016 Nov; 48(5):564-568. PubMed ID: 27765412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of bacterial species and baseline resistance on fosfomycin efficacy in urinary tract infections.
    Abbott IJ; Dekker J; van Gorp E; Wijma RA; Raaphorst MN; Klaassen CHW; Meletiadis J; Mouton JW; Peleg AY
    J Antimicrob Chemother; 2020 Apr; 75(4):988-996. PubMed ID: 31873748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyclonal Spread of Fosfomycin Resistance among Carbapenemase-Producing Members of the
    Mattioni Marchetti V; Kraftova L; Finianos M; Sourenian T; Hrabak J; Bitar I
    Microbiol Spectr; 2023 Jun; 11(3):e0009523. PubMed ID: 37098942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy.
    Sime FB; Johnson A; Whalley S; Santoyo-Castelazo A; Montgomery AB; Walters KA; Lipman J; Hope WW; Roberts JA
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
    J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae.
    Diep JK; Sharma R; Ellis-Grosse EJ; Abboud CS; Rao GG
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IS
    Kieffer N; Poirel L; Mueller L; Mancini S; Nordmann P
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
    Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
    J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae.
    Liu P; Chen S; Wu ZY; Qi M; Li XY; Liu CX
    J Glob Antimicrob Resist; 2020 Sep; 22():238-243. PubMed ID: 32061879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.